Zogenix, Inc. ZGNX
We take great care to ensure that the data presented and summarized in this overview for ZOGENIX, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in ZGNX
Top Purchases
Top Sells
About ZGNX
Insider Transactions at ZGNX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2022
|
Ashish M Sagrolikar EVP & Chief Operating Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
17,156
-100.0%
|
-
|
|
Mar 07
2022
|
Denelle J Waynick Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
584
-100.0%
|
-
|
|
Mar 07
2022
|
Stephen J Farr President & CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
92,806
-100.0%
|
-
|
|
Mar 07
2022
|
Cam L Garner Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
81,843
-100.0%
|
-
|
|
Mar 07
2022
|
Shawnte Mitchell EVP, GC & Secretary |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
605
-100.0%
|
-
|
|
Mar 07
2022
|
Bradley S. Galer EVP & Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
25,022
-100.0%
|
-
|
|
Mar 07
2022
|
Erle T Mast Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
3,027
-100.0%
|
-
|
|
Mar 07
2022
|
Gail M Farfel Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
16,606
-100.0%
|
-
|
|
Mar 07
2022
|
Renee P Tannenbaum Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
32,567
-100.0%
|
-
|
|
Mar 07
2022
|
Mark C Wiggins Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
2,500
-100.0%
|
-
|
|
Mar 07
2022
|
James B Breitmeyer Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
1,250
-100.0%
|
-
|
|
Mar 07
2022
|
Michael P Smith EVP, CFO & Treasurer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
8,016
-100.0%
|
-
|
|
Feb 01
2022
|
Erle T Mast Director |
SELL
Open market or private sale
|
Direct |
1,250
-29.23%
|
$32,500
$26.04 P/Share
|
|
Feb 01
2022
|
Erle T Mast Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+22.62%
|
$15,000
$12.0 P/Share
|
|
Jan 19
2022
|
Erle T Mast Director |
SELL
Open market or private sale
|
Direct |
15,000
-83.21%
|
$390,000
$26.09 P/Share
|
|
Jan 19
2022
|
Erle T Mast Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+28.02%
|
$195,000
$13.97 P/Share
|
|
Nov 29
2021
|
Renee P Tannenbaum Director |
SELL
Open market or private sale
|
Direct |
5,305
-14.01%
|
$58,355
$11.72 P/Share
|
|
Aug 10
2021
|
Cam L Garner Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+19.61%
|
$140,000
$14.83 P/Share
|
|
Jul 02
2021
|
Ashish M Sagrolikar EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,114
-6.45%
|
$18,938
$17.74 P/Share
|
|
Jul 02
2021
|
Ashish M Sagrolikar EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+16.86%
|
-
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders